Dr. Xiang Liu Ph.D. Net Worth

The estimated Net Worth of Xiang Liu is at least $7.93 Tysiąc dollars as of 31 January 2024. Dr Liu owns over 188 units of BlackRock Health Sciences Trust stock worth over $7,928 and over the last 3 years he sold BME stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Dr D BME stock SEC Form 4 insiders trading

Dr has made over 2 trades of the BlackRock Health Sciences Trust stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 188 units of BME stock worth $7,928 on 31 January 2024.

The largest trade he's ever made was exercising 188 units of BlackRock Health Sciences Trust stock on 31 January 2024 worth over $7,928. On average, Dr trades about 71 units every 91 days since 2022. As of 31 January 2024 he still owns at least 188 units of BlackRock Health Sciences Trust stock.

You can see the complete history of Dr Liu stock trades at the bottom of the page.

Dr. Xiang Liu Ph.D. biography

Dr. Xiang Liu Ph.D. is the Portfolio Mang. at BlackRock Health Sciences Trust.

Insiders trading at BlackRock Health Sciences Trust

Over the last 20 years, insiders at BlackRock Health Sciences Trust have traded over $27,424 worth of BlackRock Health Sciences Trust stock and bought 5,012 units worth $181,509 . The most active insiders traders include Ralph Schlosstein, Jerrold B Harris oraz Karen P Robards. On average, BlackRock Health Sciences Trust executives and independent directors trade stock every 203 days with the average trade being worth of $147,131. The most recent stock trade was executed by Kyle Mc Clements on 31 January 2024, trading 625 units of BME stock currently worth $26,356.

What does BlackRock Health Sciences Trust do?

blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines

Complete history of Dr Liu stock trades at BlackRock Health Sciences Trust i BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust executives and stock owners

BlackRock Health Sciences Trust executives and other stock owners filed with the SEC include:

• Dr. Erin Xie Ph.D.,
  Portfolio Mang.
• Thomas P. Callan C.F.A.,
  Portfolio Mang.
• Dr. Xiang Liu Ph.D.,
  Portfolio Mang.
• Jeffrey Gene Lee,
  Portfolio Mang.
• Christopher M. Accettella,
  Portfolio Mang.
• Dr. Erin Xie,
  Portfolio Mang.
• Kyle G. McClements CFA,
  Portfolio Mang.
• Thomas P. Callan C.F.A., CFA,
  Portfolio Mang.
• Charles Choon Sik Park,
  Chief Compliance Officer and Anti-Money Laundering Officer
• Xiang Liu,
  
• Jerrold B Harris,
  Director
• Richard Cavanagh,
  Director
• Robert Glenn Hubbard,
  Director
• Christopher Accettella,
  
• Michael J Castellano,
  Director
• Catherine A. Lynch,
  Director
• Karen P Robards,
  Director
• Kyle Mc Clements,
  
• H Erin Xie,
  
• W Carl Kester,
  Director
• James Laforce,
  Director
• Walter F Mondale,
  Director
• Ralph Schlosstein,
  Director
• Frank Fabozzi,
  Director
• Kathleen F Feldstein,
  Director
• James T Flynn,
  Director
• George Nicholas Iii Beckwith,
  Director
• Robert Kapito,
  President & CEO of the Trust
• Henry Gabbay,
  Director
• Dick Davis,
  Director
• Kent Dixon,
  Director
• Cynthia Egan,
  Director
• Jeffrey Gene Lee,